Medicine 2DG, developed by the DRDO to be available in the market

New Delhi: – ‘2DG’, the medicine against Coronavirus, developed by the Defence Research and Development Organisation (DRDO), is now available in the market. On Monday, the first batch of the medicine was handed over by Union Defence Minister Rajnath Singh to Union Health Minister Harsh Vardhan. This medicine will be made available in all hospitals, in the country, by the first week of June. This is a medicine developed explicitly for the treatment of Coronavirus infection. It is claimed that this medicine will play a vital role in the hospital treatment of Coronavirus infections.

This medicine, 2-Deoxy-D-glucose against Coronavirus, has been developed from the medicines used against Tumour and Cancer cells. The Drug Controller General of India allowed emergency use of this medicine on 8th May. All three trials of the 2-DG showed that the Corona patients recover faster with this and the patients’ dependence on external Oxygen is considerably reduced.

Coronavirus patients were treated with medicines like Hydroxychloroquine, Remdesivir, and Ivermectin used in other epidemics. The milder versions of Coronavirus infection were treated with medicines developed for treatment. But now, this special medicine 2DG is available for patients requiring hospital admission and dropping Oxygen levels.

The medicine is in powder form and has to be dissolved in water and consumed as per the doctor’s advice. The cost of the medicine is ₹500 to ₹600 per packet. The medicine is being manufactured at Dr Reddy’s Laboratory.